Skip to content Skip to footer
Subscribe Now

VIEWPOINTS

Viewpoints_Laurent Levy
PharmaShots Interview: Nanobiotix’s Laurent Levy Shares Insights on the P-III (NANORAY-312) Study of NBTXR3 for the Treatment of Head and Neck Squamous Cell Carcinoma
In an interview with PharmaShots, Laurent Levy, Co-Founder & CEO at Nanobiotix shares his views on the first patient enrollment of NBTXR3 in P-III (NANORAY-312) study for the treatment of head and neck squamous cell carcinoma Shots: The first patient has been enrolled in P-III (NANORAY-312) study to evaluate the efficacy & safety of NBTXR3 with/out cetuximab vs radiotherapy with/out cetuximab…
January 31, 2022
Viewpoints_Ilse Eder
PharmaShots Interview: E&E CRO Consulting’s Ilse Eder Shares Insights on the Trends of Clinical Research & New Healthcare Technologies
In an interview with PharmaShots, Ilse Eder, CEO at E&E CRO Consulting shares her views on the breakthrough healthcare technologies to improve patient outcomes Shots: Principal Technologies is an investor in the MedTech space. Its first investment is an 80% stake in E&E which is focused on helping companies earn international distribution permits via clinical studies  Principal Technologies focuses on identifying…
January 25, 2022
Viewpoints_Thomas C. Corbridge
PharmaShots Interview: GSK’s Thomas C. Corbridge Shares Insights on the New Survey Data for Severe Eosinophilic Asthma Patients
In an interview with PharmaShots, Thomas C. Corbridge, US Senior Medical Lead at GSK shares his views on the new survey and demonstrated dissatisfaction with the asthma treatment paradigm Shots: The survey was commissioned by GSK and conducted by The Harris Poll in 100 patients aged ≥18yrs. showed that a majority of SEA patients and physicians are concerned about the current state…
January 18, 2022
Viewpoints_Nikki Longwell
PharmaShots Interview: Janssen’s Nikki Longwell Shares Insights on the National Biologic Coordinators Day
In an interview with PharmaShots, Nikki Longwell, Sr. Director, Medical Science Liaisons, Immunology at Janssen shares her views on the launch of the National Biologic Coordinators Day supporting the needs of people living with autoimmune diseases Shots: The company has launched the first national awareness day “National Biologic Coordinators Day” on Nov 1 which is also known as a day…
January 17, 2022
PharmaShots Interview Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine
PharmaShots Interview: Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine
In an interview with PharmaShots, Brian Ward, Medical Officer at Medicago shares his views on the P-III study of plant-based COVID-19 vaccine in combination with GSK’s pandemic adjuvant for the treatment of COVID-19  Shots: The company reported efficacy and safety results from the P-III study of Medicago’s plant-based COVID-19 vaccine candidate + GSK’s pandemic adjuvant in ~24,000 adults aged ≥18yrs. across Canada, US, UK,…
January 12, 2022
Viewpoints_Dr. Justin Odegaard_Dr. Yoshiaki Nakamura
PharmaShots Interview: Guardant Health’s Justin Odegaard Shares Insights on the Data of Guardant360 Liquid Biopsy Test Published in Nature Medicine
In an interview with PharmaShots, Justin Odegaard, Vice President of Clinical Development and a Laboratory Director at Guardant Health & Yoshiaki Nakamura, Staff Physician in the Department of Gastroenterology and Gastrointestinal Oncology shared their views on the benefits of using the Guardant360 liquid biopsy test in P-II (TRIUMPH) study for HER2-driven metastatic colorectal cancer Shots: The P-II (TRIUMPH) study evaluates pertuzumab +…
January 5, 2022
PharmaShots Interview Janssen’s Alyssa Johnsen Shares Insights on the New Clinical data of Tremfya (guselkumab) Presented at ACR 2021 and Published in Arthritis & Rheumatology
PharmaShots Interview: Janssen’s Alyssa Johnsen Shares Insights on the New Clinical data of Tremfya (guselkumab) Presented at ACR 2021 and Published in Arthritis & Rheumatology
In an interview with PharmaShots, Alyssa Johnsen, MD, Ph.D., Vice President, Rheumatology and Maternal-Fetal Health Disease Area Leader at Janssen Research & Development shares her views on the P-III DISCOVER-1 & 2 Studies of Tremfya (guselkumab) for the treatment of psoriatic arthritis in ACR 2021 and published in Arthritis & Rheumatology Shots: The P-III DISCOVER-1 & 2 trials evaluate Tremfya (SC) vs PBO in 381 & 739…
January 4, 2022
PharmaShots Interview Alto Neuroscience’s Dr. Amit Etkin Shares Insights on the Future of Psychiatric Medicines
PharmaShots Interview: Alto Neuroscience’s Dr. Amit Etkin Shares Insights on the Future of Psychiatric Medicines
In an interview with PharmaShots, Dr. Amit Etkin, CEO and Founder of Alto Neuroscience shared his views on its clinical stage pipeline in the emerging hot precision psychiatry space. He also put his views on the funding received by the company for the development of its pipeline. Shots: Using precision psychiatry, the company’s human data R&D platform identifies brain biomarkers…
January 3, 2022
Viewpoints_Joe Eazor
PharmaShots Interview: Clario’s Joe Eazor Shares Insight on the Clinical Trial Innovation and Evidence
In an interview with PharmaShots, Joe Eazor, CEO at Clario share his views on the ERT’s merger with Bioclinica to become Clario for clinical trial innovation and evidence ERT & Bioclinica merged to become Clario, following its Apr 2021 merger agreement & to generate the clinical evidence, empower the patients &  transform their lives by providing better evidence Clario combines Bioclinica's expertise in imaging,…
December 30, 2021
Load more